1. Progression of steroid-associated osteoporosis after heart transplantation 
Jochen Cremer, MD, Martin Strüber, MD, Ingrid Wagenbreth, MD, Johannes Nischelsky, MD, Stefanos Demertzis, MD, Thomas Graeter, MD, Conny Abraham, PhD, Axel Haverich, MD 
The Annals of Thoracic Surgery 
Volume 67, Issue 1, Pages (January 1999)
DOI: /S (98)

2. Fig 1
Maintenance steroid dose (prednisone) after 1, 3, 6, 9, and 12 months in each group.
The Annals of Thoracic Surgery  , DOI: ( /S (98) )

3. Fig 2
Course of trabecular bone density (mean of T12, L1, L2, and L3) in the elcitonin and placebo groups. (∗p < 0.05.)
The Annals of Thoracic Surgery  , DOI: ( /S (98) )

4. Fig 3
Course of cortical bone density (mean of T12, L1, L2, and L3) in the elcitonin and placebo groups. (∗p < 0.05.)
The Annals of Thoracic Surgery  , DOI: ( /S (98) )

5. Fig 4
Course of trabecular bone density (mean of T12, L1, L2, and L3) in men older or younger than 40 years independent of elcitonin treatment. (∗p < 0.05.)
The Annals of Thoracic Surgery  , DOI: ( /S (98) )